Masimo Total Assets 2007-2018 | MASI

Masimo total assets from 2007 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Masimo total assets for the quarter ending September 30, 2018 were $1.096B, a 20.95% increase year-over-year.
  • Masimo total assets for 2017 were $0.91B, a 10.93% increase from 2016.
  • Masimo total assets for 2016 were $0.821B, a 36.36% increase from 2015.
  • Masimo total assets for 2015 were $0.602B, a 6.5% increase from 2014.
Masimo Annual Total Assets
(Millions of US $)
2017 $910
2016 $821
2015 $602
2014 $565
2013 $439
2012 $375
2011 $366
2010 $310
2009 $356
2008 $293
2007 $236
2006 $159
2005 $0
Masimo Quarterly Total Assets
(Millions of US $)
Q3 2018 $1,096
Q2 2018 $1,007
Q1 2018 $950
Q4 2017 $905
Q3 2017 $906
Q2 2017 $896
Q1 2017 $878
Q4 2016 $821
Q3 2016 $639
Q2 2016 $603
Q1 2016 $621
Q4 2015 $602
Q3 2015 $578
Q2 2015 $584
Q1 2015 $575
Q4 2014 $565
Q3 2014 $532
Q2 2014 $499
Q1 2014 $459
Q4 2013 $439
Q3 2013 $428
Q2 2013 $397
Q1 2013 $388
Q4 2012 $375
Q3 2012 $410
Q2 2012 $381
Q1 2012 $380
Q4 2011 $366
Q3 2011 $374
Q2 2011 $352
Q1 2011 $328
Q4 2010 $310
Q3 2010 $327
Q2 2010 $301
Q1 2010 $291
Q4 2009 $356
Q3 2009 $336
Q2 2009 $316
Q1 2009 $305
Q4 2008 $293
Q3 2008 $271
Q2 2008 $251
Q1 2008 $227
Q4 2007 $236
Q3 2007 $225
Q2 2007 $174
Q1 2007 $0
Q3 2006 $0
Q2 2006 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.825B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $101.538B 22.68
Intuitive Surgical (ISRG) United States $62.929B 59.23
Edwards Lifesciences (EW) United States $36.708B 37.59
Fresenius Medical Care AG KGaA (FMS) Germany $24.505B 16.57
IDEXX Laboratories (IDXX) United States $18.185B 49.52
ABIOMED (ABMD) United States $16.332B 107.81
Hologic (HOLX) United States $13.523B 20.45
Teleflex (TFX) United States $13.173B 29.90
DexCom (DXCM) United States $12.930B 0.00
Varian Medical Systems (VAR) United States $12.041B 30.08
STERIS (STE) United Kingdom $10.392B 26.71
Penumbra (PEN) United States $5.141B 310.42
LivaNova (LIVN) United Kingdom $4.861B 31.20
Globus Medical (GMED) United States $4.688B 29.38
Integra LifeSciences Holdings (IART) United States $4.423B 21.55
Wright Medical Group (WMGI) Netherlands $3.941B 0.00
Cantel Medical (CMD) United States $3.599B 35.50
Inogen (INGN) United States $3.000B 64.75
Tandem Diabetes Care (TNDM) United States $2.811B 0.00
Integer Holdings (ITGR) United States $2.761B 23.10
Glaukos (GKOS) United States $2.420B 0.00
AVANOS MEDICAL, INC (AVNS) United States $2.365B 21.31
OPKO Health (OPK) United States $1.612B 0.00
Nevro (NVRO) United States $1.461B 0.00
Tactile Systems Technology (TCMD) United States $1.358B 216.18
ORTHOFIX MEDICAL INC (OFIX) United States $1.244B 35.93
Accelerate Diagnostics (AXDX) United States $1.166B 0.00
Luminex (LMNX) United States $1.161B 53.14
CryoLife (CRY) United States $1.098B 118.84
Pacific Biosciences Of California (PACB) United States $1.088B 0.00
Intersect ENT (XENT) United States $1.039B 0.00
Natus Medical (BABY) United States $0.943B 19.67
Mesa Laboratories (MLAB) United States $0.900B 36.80
AngioDynamics (ANGO) United States $0.871B 28.24
ViewRay (VRAY) United States $0.791B 0.00
Veracyte (VCYT) United States $0.771B 0.00
AxoGen (AXGN) United States $0.677B 0.00
TransEnterix (TRXC) United States $0.653B 0.00
Quotient (QTNT) Switzerland $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.488B 0.00
Si-Bone (SIBN) United States $0.466B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.457B 0.00
Accuray (ARAY) United States $0.454B 0.00
Fluidigm (FLDM) United States $0.424B 0.00
GenMark Diagnostics (GNMK) United States $0.377B 0.00
Pulse Biosciences (PLSE) United States $0.344B 0.00
SeaSpine Holdings (SPNE) United States $0.324B 0.00
Neuronetics (STIM) United States $0.310B 0.00
Sientra (SIEN) United States $0.304B 0.00
IRadimed (IRMD) United States $0.292B 62.14
RTI Surgical (RTIX) United States $0.291B 46.70
Corindus Vascular Robotics (CVRS) United States $0.251B 0.00
Nuvectra (NVTR) United States $0.250B 0.00
CRH Medical (CRHM) Canada $0.234B 40.63
Helius Medical Technologies (HSDT) United States $0.173B 0.00
T2 Biosystems (TTOO) United States $0.163B 0.00
Ekso Bionics Holdings (EKSO) United States $0.126B 0.00
Sensus Healthcare (SRTS) United States $0.120B 0.00
Ra Medical Systems (RMED) United States $0.093B 0.00
ConforMIS (CFMS) United States $0.089B 0.00
Biosig Technologies (BSGM) United States $0.087B 0.00
Titan Medical (TMDI) Canada $0.083B 0.00
EDAP TMS (EDAP) France $0.081B 0.00
Apollo Endosurgery (APEN) United States $0.081B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.068B 0.00
Alphatec Holdings (ATEC) United States $0.061B 0.00
Second Sight Medical Products (EYES) United States $0.057B 0.00
Vermillion (VRML) United States $0.054B 0.00
OBALON THERPTCS (OBLN) United States $0.050B 0.00
Electromed (ELMD) United States $0.047B 24.13
Xtant Medical Holdings (XTNT) United States $0.045B 0.00
Microbot Medical (MBOT) United States $0.039B 0.00
Restoration Robotics (HAIR) United States $0.034B 0.00
Viveve Medical (VIVE) United States $0.033B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.027B 0.00
PAVmed (PAVM) United States $0.026B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
ReWalk Robotics (RWLK) Israel $0.022B 0.00
Neovasc (NVCN) Canada $0.019B 0.00
Dynatronics (DYNT) United States $0.018B 0.00
Bioanalytical Systems (BASI) United States $0.015B 47.67
American Shared Hospital Services (AMS) United States $0.015B 11.13
Nanovibronix (NAOV) United States $0.012B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Atossa Genetics (ATOS) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00